Bayard L Powell

Bayard L Powell

UNVERIFIED PROFILE

Are you Bayard L Powell?   Register this Author

Register author
Bayard L Powell

Bayard L Powell

Publications by authors named "Bayard L Powell"

Are you Bayard L Powell?   Register this Author

100Publications

3186Reads

33Profile Views

Association between glycemic control, age, and outcomes among intensively treated patients with acute myeloid leukemia.

Support Care Cancer 2019 Aug 15;27(8):2877-2884. Epub 2018 Dec 15.

Wake Forest University School of Medicine, Medical Center Blvd, Winston-Salem, NC, 27157, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-018-4582-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6571065PMC
August 2019

Inflammatory biomarkers, geriatric assessment, and treatment outcomes in acute myeloid leukemia.

J Geriatr Oncol 2019 Apr 5. Epub 2019 Apr 5.

Section on Hematology and Oncology, Wake Forest Baptist Health, Winston-Salem, NC, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jgo.2019.03.014DOI Listing
April 2019

Outcomes and changes in code status of patients with acute myeloid leukemia undergoing induction chemotherapy who were transferred to the intensive care unit.

Leuk Res 2017 11 27;62:51-55. Epub 2017 Sep 27.

Department of Internal Medicine, Medical Center Blvd., Winston-Salem, NC 27157, United States; Section on Hematology and Oncology, Medical Center Blvd, Winston-Salem, NC 27157, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2017.09.017DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5682208PMC
November 2017

Comorbidity, age, and mortality among adults treated intensively for acute myeloid leukemia (AML).

J Geriatr Oncol 2016 Jan 30;7(1):24-31. Epub 2015 Oct 30.

Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, NC, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jgo.2015.10.182DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4747801PMC
January 2016

High dose cytarabine, mitoxantrone and l-asparaginase (HAMA) salvage for relapsed or refractory acute myeloid leukemia (AML) in the elderly.

Leuk Res 2015 Sep 1;39(9):945-9. Epub 2015 Jun 1.

Internal Medicine, Section on Hematology and Oncology, Wake Forest Baptist Health, Winston-Salem, NC, United States; Cancer Biology, Comprehensive Cancer Center of Wake Forest University, Winston-Salem, NC, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2015.05.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4546894PMC
September 2015

The prognostic importance of polypharmacy in older adults treated for acute myelogenous leukemia (AML).

Leuk Res 2014 Oct 7;38(10):1184-90. Epub 2014 Jul 7.

Section on Hematology and Oncology, Wake Forest School of Medicine, Winston-Salem, NC, USA; Comprehensive Cancer Center of Wake Forest University, Winston-Salem, NC, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2014.06.018DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4182134PMC
October 2014

Epigenetics meets genetics in acute myeloid leukemia: clinical impact of a novel seven-gene score.

J Clin Oncol 2014 Feb 30;32(6):548-56. Epub 2013 Dec 30.

Guido Marcucci, Pearlly Yan, Kati Maharry, David Frankhouser, Deedra Nicolet, Klaus H. Metzeler, Jessica Kohlschmidt, Krzysztof Mrózek, Yue-Zhong Wu, Donna Bucci, John P. Curfman, Susan P. Whitman, Ann-Kathrin Eisfeld, Jason H. Mendler, Sebastian Schwind, Heiko Becker, John C. Byrd, Ramiro Garzon, Michael A. Caligiuri, Stefano Volinia, and Clara D. Bloomfield, The Ohio State University Comprehensive Cancer Center; Ralf Bundschuh, The Ohio State University, Columbus, OH; Kati Maharry, Deedra Nicolet, and Jessica Kohlschmidt, Alliance for Clinical Trials in Oncology Statistics and Data Center, Mayo Clinic, Rochester, MN; Andrew J. Carroll, University of Alabama at Birmingham, Birmingham, AL; Maria R. Baer, Greenebaum Cancer Center, University of Maryland, Baltimore, MD; Meir Wetzler, Roswell Park Cancer Institute, Buffalo; Jonathan E. Kolitz, Monter Cancer Center, Lake Success, NY; Thomas H. Carter, University of Iowa, Iowa City, IA; Bayard L. Powell, The Comprehensive Cancer Center of Wake Forest University, Winston-Salem, NC; Richard M. Stone, Dana-Farber Cancer Institute, Boston, MA; Constance Bär and Christoph Plass, German Cancer Research Center, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.50.6337DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3918538PMC
February 2014

Acute promyelocytic leukemia: progress far and wide.

Authors:
Bayard L Powell

Blood 2013 Mar;121(11):1925-6

Comprehensive Cancer Center of Wake Forest University, USA.

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/cgi/doi/10.1182/blood-2012-12-47
Publisher Site
http://dx.doi.org/10.1182/blood-2012-12-470757DOI Listing
March 2013

Arsenic trioxide in acute promyelocytic leukemia: potion not poison.

Authors:
Bayard L Powell

Expert Rev Anticancer Ther 2011 Sep;11(9):1317-9

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1586/era.11.128
Publisher Site
http://dx.doi.org/10.1586/era.11.128DOI Listing
September 2011

Exercise for older adult inpatients with acute myelogenous leukemia: A pilot study.

J Geriatr Oncol 2011 Jan;2(1):11-17

Comprehensive Cancer Center of Wake Forest University, Department of Internal Medicine, Section on Hematology and Oncology, Winston-Salem, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jgo.2010.10.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703780PMC
January 2011

Treatment of patients with acute promyelocytic leukemia: a consensus statement on risk-adapted approaches to therapy.

Clin Lymphoma Myeloma Leuk 2010 Oct;10 Suppl 3:S122-6

Northwestern University Feinberg School of Medicine, 676 N. St. Clair, Chicago, IL 60611, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/CLML.2010.s.023DOI Listing
October 2010

Risk-adapted approaches to therapy for high-risk acute promyelocytic leukemia.

Clin Lymphoma Myeloma Leuk 2010 Oct;10 Suppl 3:S135-8

Physicians' Education Resource, Dallas, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/CLML.2010.s.026DOI Listing
October 2010

Hyperleukocytosis from arsenic trioxide.

Pediatr Blood Cancer 2008 Jun;50(6):1265-7

Department of Pediatrics, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.21532DOI Listing
June 2008

What role does gemtuzumab ozogamicin have in the treatment of acute myelogenous leukemia?

Curr Hematol Malig Rep 2007 May;2(2):104-10

Section on Hematology and Oncology, Department of Medicine,Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11899-007-0015-1
Publisher Site
http://dx.doi.org/10.1007/s11899-007-0015-1DOI Listing
May 2007

Philadelphia chromosome positive myelodysplastic syndrome and acute myeloid leukemia-retrospective study and review of literature.

Leuk Res 2004 Jun;28(6):579-86

Department of Internal Medicine, Comprehensive Cancer Center of Wake Forest University, Medical Center Boulevard, Winston-Salem, NC 27157, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2003.10.027DOI Listing
June 2004

A phase II study of DT fusion protein denileukin diftitox in patients with fludarabine-refractory chronic lymphocytic leukemia.

Clin Cancer Res 2003 Sep;9(10 Pt 1):3555-61

Wake Forest University Baptist Medical Center, Winston-Salem, North Carolina 27157, USA.

View Article

Download full-text PDF

Source
September 2003